Effect of statins on metabolism of apo-B-containing lipoproteins in hypertriglyceridemic men. (Q41731952)

8 October 2017

1 reference

title

Effect of statins on metabolism of apo-B-containing lipoproteins in hypertriglyceridemic men. (English)

1 reference

8 October 2017

1

G L Vega

1 reference

8 October 2017

2

S M Grundy

1 reference

8 October 2017

language of work or name

English

0 references

publication date

1 February 1998

1 reference

American Journal of Cardiology

8 October 2017

published in

1 reference

8 October 2017

volume

81

1 reference

8 October 2017

issue

4A

1 reference

8 October 2017

page(s)

36B-42B

1 reference

HMG-CoA reductase inhibitors for treatment of hypercholesterolemia

8 October 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900036-8

Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. West of Scotland Coronary Prevention Study Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900036-8

The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. Cholesterol and Recurrent Events Trial investigators

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900036-8

Familial lipoprotein disorders in patients with premature coronary artery disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900036-8

Metabolic basis of primary hypercholesterolemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900036-8

McCollum Award Lecture, 1993: triglyceride-rich lipoproteins and atherosclerosis--new perspectives

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900036-8

Lovastatin therapy in familial dysbetalipoproteinemia: effects on kinetics of apolipoprotein B

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900036-8

Lovastatin therapy in nephrotic hyperlipidemia: effects on lipoprotein metabolism

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900036-8

Metabolism of low density lipoproteins in nephrotic dyslipidemia: comparison of hypercholesterolemia alone and combined hyperlipidemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900036-8

Quantitative studies of very low density lipoprotein: conversion to low density lipoprotein in normal controls and primary hyperlipidaemic states and the role of direct secretion of low density lipoprotein in heterozygous familial hypercholesterolae

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900036-8

Low density lipoprotein metabolism in familial combined hyperlipidemia. Mechanism of the multiple lipoprotein phenotypic expression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900036-8

Low density lipoprotein metabolism in familial combined hyperlipidemia and familial hypercholesterolemia: kinetic analysis using an integrated model

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900036-8

The association of increased levels of intermediate-density lipoproteins with smoking and with coronary artery disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900036-8

Determinants of plasma HDL-cholesterol in hypertriglyceridemic patients. Role of cholesterol-ester transfer protein and lecithin cholesteryl acyl transferase

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900036-8

Abnormal metabolism of free fatty acids in hypertriglyceridaemic men: apparent insulin resistance of adipose tissue.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900036-8

Changes of lipolytic enzymes cluster with insulin resistance syndrome. Botnia Study Group.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900036-8

An apolipoprotein CIII haplotype protective against hypertriglyceridemia is specified by promoter and 3' untranslated region polymorphisms

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900036-8

Reduced HDL2 cholesterol subspecies and elevated postheparin hepatic lipase activity in older men with abdominal obesity and asymptomatic myocardial ischemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900036-8

Lovastatin therapy in receptor-negative homozygous familial hypercholesterolemia: Lack of effect on low-density lipoprotein concentrations or turnover

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900036-8

Comparison of pravastatin with crystalline nicotinic acid monotherapy in treatment of combined hyperlipidemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900036-8

10.1016/S0002-9149(98)00036-8

7 January 2021

Identifiers

DOI

1 reference

8 October 2017

1 reference